[English] 日本語
Yorodumi
- EMDB-20806: Single-Particle Cryo-EM Structure of Plasmodium falciparum Chloro... -

+
Open data


ID or keywords:

Loading...

-
Basic information

Entry
Database: EMDB / ID: EMD-20806
TitleSingle-Particle Cryo-EM Structure of Plasmodium falciparum Chloroquine Resistance Transporter (PfCRT) 7G8 Isoform
Map dataSharpened map
Sample
  • Organelle or cellular component: Plasmodium falciparum Chloroquine Resistance Transporter (PfCRT) 7G8 Isoform Complexed with Fab
    • Organelle or cellular component: Plasmodium falciparum Chloroquine Resistance Transporter (PfCRT)
      • Protein or peptide: Chloroquine resistance transporter
    • Organelle or cellular component: Antigen-binding fragment (Fab)
      • Protein or peptide: Fab Heavy Chain
      • Protein or peptide: Fab Light Chain
  • Ligand: CHOLESTEROL HEMISUCCINATE
KeywordsTransporter / drug resistance / digestive vacuole of malaria parasite / nanodisc / MEMBRANE PROTEIN
Function / homologyChloroquine-resistance transporter-like / Chloroquine resistance transporter / CRT-like, chloroquine-resistance transporter-like / vacuolar membrane / amino acid transport / xenobiotic transmembrane transporter activity / Chloroquine resistance transporter
Function and homology information
Biological speciesPlasmodium falciparum 7G8 (eukaryote) / Homo sapiens (human) / Plasmodium falciparum (isolate 7G8) (eukaryote)
Methodsingle particle reconstruction / cryo EM / Resolution: 3.3 Å
AuthorsKim J / Tan YZ
Funding support United States, 9 items
OrganizationGrant numberCountry
National Institutes of Health/National Institute of General Medical Sciences (NIH/NIGMS)R01 GM111980 United States
National Institutes of Health/National Institute of General Medical Sciences (NIH/NIGMS)R37 AI50234 United States
National Institutes of Health/National Institute of General Medical Sciences (NIH/NIGMS)R01 AI124678 United States
National Institutes of Health/National Institute of General Medical Sciences (NIH/NIGMS)R01 GM119396 United States
National Institutes of Health/National Institute of General Medical Sciences (NIH/NIGMS)R01 AI506312 United States
National Institutes of Health/National Institute of General Medical Sciences (NIH/NIGMS)AI111962 United States
National Institutes of Health/National Institute of General Medical Sciences (NIH/NIGMS)T32 HL120826 United States
National Institutes of Health/National Institute of General Medical Sciences (NIH/NIGMS)P41 GM103310 United States
National Institutes of Health/National Institute of General Medical Sciences (NIH/NIGMS)P41 GM116799 United States
CitationJournal: Nature / Year: 2019
Title: Structure and drug resistance of the Plasmodium falciparum transporter PfCRT.
Authors: Jonathan Kim / Yong Zi Tan / Kathryn J Wicht / Satchal K Erramilli / Satish K Dhingra / John Okombo / Jeremie Vendome / Laura M Hagenah / Sabrina I Giacometti / Audrey L Warren / Kamil Nosol ...Authors: Jonathan Kim / Yong Zi Tan / Kathryn J Wicht / Satchal K Erramilli / Satish K Dhingra / John Okombo / Jeremie Vendome / Laura M Hagenah / Sabrina I Giacometti / Audrey L Warren / Kamil Nosol / Paul D Roepe / Clinton S Potter / Bridget Carragher / Anthony A Kossiakoff / Matthias Quick / David A Fidock / Filippo Mancia /
Abstract: The emergence and spread of drug-resistant Plasmodium falciparum impedes global efforts to control and eliminate malaria. For decades, treatment of malaria has relied on chloroquine (CQ), a safe and ...The emergence and spread of drug-resistant Plasmodium falciparum impedes global efforts to control and eliminate malaria. For decades, treatment of malaria has relied on chloroquine (CQ), a safe and affordable 4-aminoquinoline that was highly effective against intra-erythrocytic asexual blood-stage parasites, until resistance arose in Southeast Asia and South America and spread worldwide. Clinical resistance to the chemically related current first-line combination drug piperaquine (PPQ) has now emerged regionally, reducing its efficacy. Resistance to CQ and PPQ has been associated with distinct sets of point mutations in the P. falciparum CQ-resistance transporter PfCRT, a 49-kDa member of the drug/metabolite transporter superfamily that traverses the membrane of the acidic digestive vacuole of the parasite. Here we present the structure, at 3.2 Å resolution, of the PfCRT isoform of CQ-resistant, PPQ-sensitive South American 7G8 parasites, using single-particle cryo-electron microscopy and antigen-binding fragment technology. Mutations that contribute to CQ and PPQ resistance localize primarily to moderately conserved sites on distinct helices that line a central negatively charged cavity, indicating that this cavity is the principal site of interaction with the positively charged CQ and PPQ. Binding and transport studies reveal that the 7G8 isoform binds both drugs with comparable affinities, and that these drugs are mutually competitive. The 7G8 isoform transports CQ in a membrane potential- and pH-dependent manner, consistent with an active efflux mechanism that drives CQ resistance, but does not transport PPQ. Functional studies on the newly emerging PfCRT F145I and C350R mutations, associated with decreased PPQ susceptibility in Asia and South America, respectively, reveal their ability to mediate PPQ transport in 7G8 variant proteins and to confer resistance in gene-edited parasites. Structural, functional and in silico analyses suggest that distinct mechanistic features mediate the resistance to CQ and PPQ in PfCRT variants. These data provide atomic-level insights into the molecular mechanism of this key mediator of antimalarial treatment failures.
History
DepositionOct 5, 2019-
Header (metadata) releaseDec 4, 2019-
Map releaseDec 4, 2019-
UpdateNov 6, 2024-
Current statusNov 6, 2024Processing site: RCSB / Status: Released

-
Structure visualization

Movie
  • Surface view with section colored by density value
  • Surface level: 8
  • Imaged by UCSF Chimera
  • Download
  • Surface view colored by height
  • Surface level: 8
  • Imaged by UCSF Chimera
  • Download
  • Surface view with fitted model
  • Atomic models: PDB-6ukj
  • Surface level: 8
  • Imaged by UCSF Chimera
  • Download
Movie viewer
Structure viewerEM map:
SurfViewMolmilJmol/JSmol
Supplemental images

Downloads & links

-
Map

FileDownload / File: emd_20806.map.gz / Format: CCP4 / Size: 103 MB / Type: IMAGE STORED AS FLOATING POINT NUMBER (4 BYTES)
AnnotationSharpened map
Projections & slices

Image control

Size
Brightness
Contrast
Others
AxesX (Sec.)Y (Row.)Z (Col.)
1.04 Å/pix.
x 300 pix.
= 310.5 Å
1.04 Å/pix.
x 300 pix.
= 310.5 Å
1.04 Å/pix.
x 300 pix.
= 310.5 Å

Surface

Projections

Slices (1/3)

Slices (1/2)

Slices (2/3)

Images are generated by Spider.

Voxel sizeX=Y=Z: 1.035 Å
Density
Contour LevelBy AUTHOR: 8.0 / Movie #1: 8
Minimum - Maximum-18.204409999999999 - 42.020454000000001
Average (Standard dev.)-0.000000000001205 (±1.0)
SymmetrySpace group: 1
Details

EMDB XML:

Map geometry
Axis orderZYX
Origin000
Dimensions300300300
Spacing300300300
CellA=B=C: 310.5 Å
α=β=γ: 90.0 °

CCP4 map header:

modeImage stored as Reals
Å/pix. X/Y/Z1.0351.0351.035
M x/y/z300300300
origin x/y/z0.0000.0000.000
length x/y/z310.500310.500310.500
α/β/γ90.00090.00090.000
start NX/NY/NZ000
NX/NY/NZ300300300
MAP C/R/S321
start NC/NR/NS000
NC/NR/NS300300300
D min/max/mean-18.20442.020-0.000

-
Supplemental data

+
Mask #1

Fileemd_20806_msk_1.map
Projections & Slices
AxesZYX

Projections

Slices (1/2)
Density Histograms

+
Mask #2

Fileemd_20806_msk_2.map
Projections & Slices
AxesZYX

Projections

Slices (1/2)
Density Histograms

+
Additional map: Unsharpened map

Fileemd_20806_additional_1.map
AnnotationUnsharpened map
Projections & Slices
AxesZYX

Projections

Slices (1/2)
Density Histograms

+
Additional map: Local resolution map

Fileemd_20806_additional_2.map
AnnotationLocal resolution map
Projections & Slices
AxesZYX

Projections

Slices (1/2)
Density Histograms

+
Additional map: 3DFSC - PfCRT with Fab, Raw

Fileemd_20806_additional_3.map
Annotation3DFSC - PfCRT with Fab, Raw
Projections & Slices
AxesZYX

Projections

Slices (1/2)
Density Histograms

+
Additional map: 3DFSC - PfCRT with Fab, Thresholded

Fileemd_20806_additional_4.map
Annotation3DFSC - PfCRT with Fab, Thresholded
Projections & Slices
AxesZYX

Projections

Slices (1/2)
Density Histograms

+
Additional map: 3DFSC - PfCRT with Fab, Thresholded and Binarized

Fileemd_20806_additional_5.map
Annotation3DFSC - PfCRT with Fab, Thresholded and Binarized
Projections & Slices
AxesZYX

Projections

Slices (1/2)
Density Histograms

+
Additional map: 3DFSC - PfCRT only, Raw

Fileemd_20806_additional_6.map
Annotation3DFSC - PfCRT only, Raw
Projections & Slices
AxesZYX

Projections

Slices (1/2)
Density Histograms

+
Additional map: 3DFSC - PfCRT Only, Thresholded

Fileemd_20806_additional_7.map
Annotation3DFSC - PfCRT Only, Thresholded
Projections & Slices
AxesZYX

Projections

Slices (1/2)
Density Histograms

+
Additional map: 3DFSC - PfCRT only, Thresholded and binarized

Fileemd_20806_additional_8.map
Annotation3DFSC - PfCRT only, Thresholded and binarized
Projections & Slices
AxesZYX

Projections

Slices (1/2)
Density Histograms

+
Half map: Half map 1

Fileemd_20806_half_map_1.map
AnnotationHalf map 1
Projections & Slices
AxesZYX

Projections

Slices (1/2)
Density Histograms

+
Half map: Half map 2

Fileemd_20806_half_map_2.map
AnnotationHalf map 2
Projections & Slices
AxesZYX

Projections

Slices (1/2)
Density Histograms

-
Sample components

-
Entire : Plasmodium falciparum Chloroquine Resistance Transporter (PfCRT) ...

EntireName: Plasmodium falciparum Chloroquine Resistance Transporter (PfCRT) 7G8 Isoform Complexed with Fab
Components
  • Organelle or cellular component: Plasmodium falciparum Chloroquine Resistance Transporter (PfCRT) 7G8 Isoform Complexed with Fab
    • Organelle or cellular component: Plasmodium falciparum Chloroquine Resistance Transporter (PfCRT)
      • Protein or peptide: Chloroquine resistance transporter
    • Organelle or cellular component: Antigen-binding fragment (Fab)
      • Protein or peptide: Fab Heavy Chain
      • Protein or peptide: Fab Light Chain
  • Ligand: CHOLESTEROL HEMISUCCINATE

-
Supramolecule #1: Plasmodium falciparum Chloroquine Resistance Transporter (PfCRT) ...

SupramoleculeName: Plasmodium falciparum Chloroquine Resistance Transporter (PfCRT) 7G8 Isoform Complexed with Fab
type: organelle_or_cellular_component / ID: 1 / Parent: 0 / Macromolecule list: #1-#3
Molecular weightTheoretical: 102 KDa

-
Supramolecule #2: Plasmodium falciparum Chloroquine Resistance Transporter (PfCRT)

SupramoleculeName: Plasmodium falciparum Chloroquine Resistance Transporter (PfCRT)
type: organelle_or_cellular_component / ID: 2 / Parent: 1 / Macromolecule list: #1
Source (natural)Organism: Plasmodium falciparum 7G8 (eukaryote)
Molecular weightTheoretical: 49 KDa

-
Supramolecule #3: Antigen-binding fragment (Fab)

SupramoleculeName: Antigen-binding fragment (Fab) / type: organelle_or_cellular_component / ID: 3 / Parent: 1 / Macromolecule list: #2-#3
Source (natural)Organism: Homo sapiens (human)
Molecular weightTheoretical: 50 KDa

-
Macromolecule #1: Chloroquine resistance transporter

MacromoleculeName: Chloroquine resistance transporter / type: protein_or_peptide / ID: 1 / Number of copies: 1 / Enantiomer: LEVO
Source (natural)Organism: Plasmodium falciparum (isolate 7G8) (eukaryote) / Strain: isolate 7G8
Molecular weightTheoretical: 53.074461 KDa
Recombinant expressionOrganism: Homo sapiens (human)
SequenceString: MGRAKFASKK NNQKNSSKND ERYRELDNLV QEGNGSRLGG GSCLGKCAHV FKLIFKEIKD NIFIYILSII YLSVSVMNTI FAKRTLNKI GNYSFVTSET HNFICMIMFF IVYSLFGNKK GNSKERHRSF NLQFFAISML DACSVILAFI GLTRTTGNIQ S FVLQLSIP ...String:
MGRAKFASKK NNQKNSSKND ERYRELDNLV QEGNGSRLGG GSCLGKCAHV FKLIFKEIKD NIFIYILSII YLSVSVMNTI FAKRTLNKI GNYSFVTSET HNFICMIMFF IVYSLFGNKK GNSKERHRSF NLQFFAISML DACSVILAFI GLTRTTGNIQ S FVLQLSIP INMFFCFLIL RYRYHLYNYL GAVIIVVTIA LVEMKLSFET QEENSIIFNL VLISSLIPVC FSNMTREIVF KK YKIDILR LNAMVSFFQL FTSCLILPVY TLPFLKQLHL PYNEIWTNIK NGFACLFLGR NTVVENCGLG MAKLCDDCDG AWK TFALFS FFDICDNLIT SYIIDKFSTM TYTIVSCIQG PALAIAYYFK FLAGDVVREP RLLDFVTLFG YLFGSIIYRV GNII LERKK MRNEENEDSE GELTNVDSII TQAAAGGGSG GGSENLYFQG SHHHHHHHHH HWSHPQFEK

UniProtKB: Chloroquine resistance transporter

-
Macromolecule #2: Fab Heavy Chain

MacromoleculeName: Fab Heavy Chain / type: protein_or_peptide / ID: 2 / Number of copies: 1 / Enantiomer: LEVO
Source (natural)Organism: Homo sapiens (human)
Molecular weightTheoretical: 25.737631 KDa
Recombinant expressionOrganism: Escherichia coli (E. coli)
SequenceString: EISEVQLVES GGGLVQPGGS LRLSCAASGF NVSYSYIHWV RQAPGKGLEW VASIYPYSGY TSYADSVKGR FTISADTSKN TAYLQMNSL RAEDTAVYYC ARYGSNYSFW YRGSSVTYAI DYWGQGTLVT VSSASTKGPS VFPLAPSSKS TSGGTAALGC L VKDYFPEP ...String:
EISEVQLVES GGGLVQPGGS LRLSCAASGF NVSYSYIHWV RQAPGKGLEW VASIYPYSGY TSYADSVKGR FTISADTSKN TAYLQMNSL RAEDTAVYYC ARYGSNYSFW YRGSSVTYAI DYWGQGTLVT VSSASTKGPS VFPLAPSSKS TSGGTAALGC L VKDYFPEP VTVSWNSGAL TSGVHTFPAV LQSSGLYSLS SVVTVPSSSL GTQTYICNVN HKPSNTKVDK KVEPKSCDKT HT C

-
Macromolecule #3: Fab Light Chain

MacromoleculeName: Fab Light Chain / type: protein_or_peptide / ID: 3 / Number of copies: 1 / Enantiomer: LEVO
Source (natural)Organism: Homo sapiens (human)
Molecular weightTheoretical: 23.355898 KDa
Recombinant expressionOrganism: Escherichia coli (E. coli)
SequenceString: SDIQMTQSPS SLSASVGDRV TITCRASQSV SSAVAWYQQK PGKAPKLLIY SASSLYSGVP SRFSGSRSGT DFTLTISSLQ PEDFATYYC QQSSTWPITF GQGTKVEIKR TVAAPSVFIF PPSDSQLKSG TASVVCLLNN FYPREAKVQW KVDNALQSGN S QESVTEQD ...String:
SDIQMTQSPS SLSASVGDRV TITCRASQSV SSAVAWYQQK PGKAPKLLIY SASSLYSGVP SRFSGSRSGT DFTLTISSLQ PEDFATYYC QQSSTWPITF GQGTKVEIKR TVAAPSVFIF PPSDSQLKSG TASVVCLLNN FYPREAKVQW KVDNALQSGN S QESVTEQD SKDSTYSLSS TLTLSKADYE KHKVYACEVT HQGLSSPVTK SFNRGEC

-
Macromolecule #4: CHOLESTEROL HEMISUCCINATE

MacromoleculeName: CHOLESTEROL HEMISUCCINATE / type: ligand / ID: 4 / Number of copies: 1 / Formula: Y01
Molecular weightTheoretical: 486.726 Da
Chemical component information

ChemComp-Y01:
CHOLESTEROL HEMISUCCINATE

-
Experimental details

-
Structure determination

Methodcryo EM
Processingsingle particle reconstruction
Aggregation stateparticle

-
Sample preparation

Concentration1.56 mg/mL
BufferpH: 7
Component:
ConcentrationFormulaName
20.0 mMC8H18N2O4SHEPES
150.0 mMNaClSodium Chloride

Details: Solution was filtered and degassed.
GridModel: UltrAuFoil / Material: GOLD / Mesh: 300 / Pretreatment - Type: PLASMA CLEANING / Pretreatment - Time: 7 sec. / Pretreatment - Atmosphere: OTHER
VitrificationCryogen name: ETHANE / Chamber humidity: 80 % / Chamber temperature: 279 K / Instrument: LEICA EM GP / Details: Blot for 2 seconds before plunging..
DetailsProtein was incorporated into lipid nanodiscs and complexed with Fab.

-
Electron microscopy

MicroscopeFEI TITAN KRIOS
Specialist opticsSpherical aberration corrector: Cs corrector was used. / Energy filter - Name: GIF Bioquantum / Energy filter - Slit width: 20 eV
Image recordingFilm or detector model: GATAN K2 QUANTUM (4k x 4k) / Detector mode: COUNTING / Digitization - Dimensions - Width: 3838 pixel / Digitization - Dimensions - Height: 3710 pixel / Digitization - Frames/image: 1-80 / Number grids imaged: 1 / Number real images: 3377 / Average exposure time: 6.0 sec. / Average electron dose: 91.56 e/Å2
Electron beamAcceleration voltage: 300 kV / Electron source: FIELD EMISSION GUN
Electron opticsIllumination mode: FLOOD BEAM / Imaging mode: BRIGHT FIELD / Cs: 0.001 mm / Nominal defocus max: 0.0018000000000000002 µm / Nominal defocus min: 0.0012 µm / Nominal magnification: 215000
Sample stageSpecimen holder model: FEI TITAN KRIOS AUTOGRID HOLDER / Cooling holder cryogen: NITROGEN
Experimental equipment
Model: Titan Krios / Image courtesy: FEI Company

+
Image processing

DetailsEnergy filter slit width of 20 eV was used during the collection and was aligned automatically every hour using Leginon.
Particle selectionNumber selected: 183241
Startup modelType of model: INSILICO MODEL / In silico model: Ab initio model / Details: Ab initio model was generated in CryoSPARC
Final reconstructionNumber classes used: 1 / Applied symmetry - Point group: C1 (asymmetric) / Algorithm: BACK PROJECTION / Resolution.type: BY AUTHOR / Resolution: 3.3 Å / Resolution method: FSC 0.143 CUT-OFF / Software - Name: cisTEM (ver. 1)
Details: CisTEM was used to reconstruct the final map using original (non-signal subtracted) particles.
Number images used: 17030
Initial angle assignmentType: MAXIMUM LIKELIHOOD / Software - Name: cryoSPARC (ver. 2) / Details: Non-uniform refinement in CryoSPARC was used.
Final angle assignmentType: MAXIMUM LIKELIHOOD / Software - Name: cryoSPARC (ver. 2) / Details: Non-uniform refinement in CryoSPARC was used.
Final 3D classificationNumber classes: 2 / Avg.num./class: 17841 / Software - Name: cryoSPARC (ver. 2)
Details: Ab initio refinement using 2 models in CryoSPARC was used for classification.
FSC plot (resolution estimation)

-
Atomic model buiding 1

Initial model
PDB IDChain

chain_id: H, source_name: PDB, initial_model_type: experimental model

chain_id: L, source_name: PDB, initial_model_type: experimental model
DetailsRosetta was used to generate an ab initio model for the PfCRT using the map. 4XMM chains H and L were used as starting point to model the Fab.
RefinementSpace: REAL / Protocol: AB INITIO MODEL
Output model

PDB-6ukj:
Single-Particle Cryo-EM Structure of Plasmodium falciparum Chloroquine Resistance Transporter (PfCRT) 7G8 Isoform

+
About Yorodumi

-
News

-
Feb 9, 2022. New format data for meta-information of EMDB entries

New format data for meta-information of EMDB entries

  • Version 3 of the EMDB header file is now the official format.
  • The previous official version 1.9 will be removed from the archive.

Related info.:EMDB header

External links:wwPDB to switch to version 3 of the EMDB data model

-
Aug 12, 2020. Covid-19 info

Covid-19 info

URL: https://pdbj.org/emnavi/covid19.php

New page: Covid-19 featured information page in EM Navigator.

Related info.:Covid-19 info / Mar 5, 2020. Novel coronavirus structure data

+
Mar 5, 2020. Novel coronavirus structure data

Novel coronavirus structure data

Related info.:Yorodumi Speices / Aug 12, 2020. Covid-19 info

External links:COVID-19 featured content - PDBj / Molecule of the Month (242):Coronavirus Proteases

+
Jan 31, 2019. EMDB accession codes are about to change! (news from PDBe EMDB page)

EMDB accession codes are about to change! (news from PDBe EMDB page)

  • The allocation of 4 digits for EMDB accession codes will soon come to an end. Whilst these codes will remain in use, new EMDB accession codes will include an additional digit and will expand incrementally as the available range of codes is exhausted. The current 4-digit format prefixed with “EMD-” (i.e. EMD-XXXX) will advance to a 5-digit format (i.e. EMD-XXXXX), and so on. It is currently estimated that the 4-digit codes will be depleted around Spring 2019, at which point the 5-digit format will come into force.
  • The EM Navigator/Yorodumi systems omit the EMD- prefix.

Related info.:Q: What is EMD? / ID/Accession-code notation in Yorodumi/EM Navigator

External links:EMDB Accession Codes are Changing Soon! / Contact to PDBj

+
Jul 12, 2017. Major update of PDB

Major update of PDB

  • wwPDB released updated PDB data conforming to the new PDBx/mmCIF dictionary.
  • This is a major update changing the version number from 4 to 5, and with Remediation, in which all the entries are updated.
  • In this update, many items about electron microscopy experimental information are reorganized (e.g. em_software).
  • Now, EM Navigator and Yorodumi are based on the updated data.

External links:wwPDB Remediation / Enriched Model Files Conforming to OneDep Data Standards Now Available in the PDB FTP Archive

-
Yorodumi

Thousand views of thousand structures

  • Yorodumi is a browser for structure data from EMDB, PDB, SASBDB, etc.
  • This page is also the successor to EM Navigator detail page, and also detail information page/front-end page for Omokage search.
  • The word "yorodu" (or yorozu) is an old Japanese word meaning "ten thousand". "mi" (miru) is to see.

Related info.:EMDB / PDB / SASBDB / Comparison of 3 databanks / Yorodumi Search / Aug 31, 2016. New EM Navigator & Yorodumi / Yorodumi Papers / Jmol/JSmol / Function and homology information / Changes in new EM Navigator and Yorodumi

Read more